Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Popliteal and Saphenous Block for Ankle Fracture Surgery
NCT01923623Phase 4Withdrawn
- Sponsor
- Herlev Hospital
- Start
- Jul 2013
- Primary completion
- Jul 2013
- Modality
- Orthosteric Ligands
01
Overview
A Phase 4 trial of ropivacaine in ankle fracture, sponsored by Herlev Hospital. Planned start Jul 2013; status: withdrawn.
02
Drugs
ropivacaine
03
Conditions
ankle fracture
Beyond the preview
Go deeper on NCT01923623.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01923623.